^
    4ms
    A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery (clinicaltrials.gov)
    P2, N=114, Recruiting, Oncoinvent AS
    New P2 trial • Surgery • Metastases
    |
    Radspherin
    8ms
    Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC (clinicaltrials.gov)
    P1/2, N=67, Active, not recruiting, Oncoinvent AS | Recruiting --> Active, not recruiting
    Enrollment closed
    |
    Radspherin
    8ms
    Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis (clinicaltrials.gov)
    P1, N=49, Active, not recruiting, Oncoinvent AS | Recruiting --> Active, not recruiting
    Enrollment closed
    |
    Radspherin
    over1year
    Effect of Intraperitoneal Radium-Labelled Microparticles on Compartmentalized Inflammation After Cytoreductive Surgery and Hypertherm Intraperitoneal Chemotherapy. (PubMed, Technol Cancer Res Treat)
    Our study showed a predominately local rather than systemic inflammatory response to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Radspherin® had overall modest impact on the inflammation.
    Journal • Surgery
    |
    IFNG (Interferon, gamma) • CCL4 (Chemokine (C-C motif) ligand 4) • IL1R1 (Interleukin 1 receptor, type I)
    |
    Radspherin